Cargando…
Recent studies of the molecular mechanism of lusitropy due to phosphorylation of cardiac troponin I by protein kinase A
Ca(2+) acts on troponin and tropomyosin to switch the thin filament on and off, however in cardiac muscle a more graded form of regulation is essential to tailor cardiac output to the body’s needs. This is achieved by the action of adrenaline on β1 receptors of heart muscle cells leading to enhanced...
Autor principal: | Marston, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541847/ https://www.ncbi.nlm.nih.gov/pubmed/36131171 http://dx.doi.org/10.1007/s10974-022-09630-4 |
Ejemplares similares
-
Suppression of lusitropy as a disease mechanism in cardiomyopathies
por: Marston, Steven, et al.
Publicado: (2023) -
Dynasore Protects Mitochondria and Improves Cardiac Lusitropy in Langendorff Perfused Mouse Heart
por: Gao, Danchen, et al.
Publicado: (2013) -
Modulation of Structure
and Dynamics of Cardiac Troponin
by Phosphorylation and Mutations Revealed by Molecular Dynamics Simulations
por: Yang, Zeyu, et al.
Publicado: (2023) -
Cardiac inotropy, lusitropy, and Ca(2+) handling with major metabolic substrates in rat heart
por: Zhao, Zai Hao, et al.
Publicado: (2016) -
The Importance of Intrinsically Disordered Segments of Cardiac Troponin in Modulating Function by Phosphorylation and Disease-Causing Mutations
por: Papadaki, Maria, et al.
Publicado: (2016)